ReviewFrontiers in immunology

Fighting the Host Reaction to SARS-COv-2 in Critically Ill Patients: The Possible Contribution of Off-Label Drugs.

Stefania Scala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.